Patents by Inventor Elizabeth S. Ward

Elizabeth S. Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080299618
    Abstract: The present invention relates to single domain ligands derived from molecules in the immunoglobulin (Ig) superfamily, receptors comprising at least one such ligand, methods for cloning, amplifying and expressing DNA sequences encoding such ligands, preferably using the polymerase chain reaction, methods for the use of said DNA sequences in the productions of Ig-type molecules and said ligands or receptors, and the use of said ligand or receptors in therapy, diagnosis or catalysis.
    Type: Application
    Filed: May 27, 2008
    Publication date: December 4, 2008
    Applicant: MEDICAL RESEARCH COUNCIL
    Inventors: Gregory P. WINTER, Elizabeth S. Ward, Detlef Gussow
  • Patent number: 6623957
    Abstract: Variable domain murine T-cell receptor genes have been isolated and used to construct cloning and expression vectors. V&agr;, V&bgr;, and single chain V&agr;-V&bgr; fragments have been expressed as secreted domains in Escherichia coli using the vectors. The domains are secreted into the culture supernatant in milligram quantities. The single domains and the single chain T-cell receptors are folded into &bgr;-pleated sheet structures similar to those of immunoglobulin variable domains. The secreted fragments may be useful for immunization to generate anti-clonotypic antibodies, in vaccination or for high resolution structural studies. The genes encoding these domains may also serve as templates for in vitro mutagenesis and improvement of affinities of the TCR fragments for their interaction with cognate peptide-MHC complexes.
    Type: Grant
    Filed: June 4, 2002
    Date of Patent: September 23, 2003
    Assignee: Board of Regents University of Texas System
    Inventor: Elizabeth S. Ward
  • Publication number: 20030082814
    Abstract: Variable domain murine T-cell receptor genes have been isolated and used to construct cloning and expression vectors. V&agr;, V&bgr;, and single chain V&agr;-V&bgr; fragments have been expressed as secreted domains in Escherichia coli using the vectors. The domains are secreted into the culture supernatant in milligram quantities. The single domains and the single chain T-cell receptors are folded into &bgr;-pleated sheet structures similar to those of immunoglobulin variable domains. The secreted fragments may be useful for immunization to generate anti-clonotypic antibodies, in vaccination or for high resolution structural studies. The genes encoding these domains may also serve as templates for in vitro mutagenesis and improvement of affinities of the TCR fragments for their interaction with cognate peptide-MHC complexes.
    Type: Application
    Filed: June 4, 2002
    Publication date: May 1, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventor: Elizabeth S. Ward
  • Patent number: 6399368
    Abstract: Variable domain murine T-cell receptor genes have been isolated and used to construct cloning and expression vectors. V&agr;, V&bgr; and single chain V&agr;-V&bgr; fragments have been expressed as secreted domains in Escherichia coli using the vectors. The domains are secreted into the culture supernatant in milligram quantities. The single domains and the single chain T-cell receptors are folded into &bgr;-pleated sheet structures similar to those of immunoglobulin variable domains. The secreted fragments may be useful for immunization to generate anti-clonotypic antibodies, in vaccination or for high resolution structural studies. The genes encoding these domains may also serve as templates for in vitro mutagenesis and improvement of affinities of the TCR fragments for their interaction with cognate peptide-MHC complexes.
    Type: Grant
    Filed: December 9, 1994
    Date of Patent: June 4, 2002
    Assignee: Board of Regents, The University of Texas System
    Inventor: Elizabeth S. Ward
  • Patent number: 4918006
    Abstract: Recombinant plasmids containing the larvicidal delta-endotoxin gene were constructed by inserting HindIII fragments of the Bacillus thuringiensis var. israelensis 72-75 Md plasmid into the Escherichia coli vector pUC12. Two recombinants producing a 27-kdal toxin (pIP173 and pIP174) were indentified by screening clones in an E. coli in vitro transcription-translation system. Both recombinants comprised pUC12 and common 9.7 kb HindIII fragment of the B. thuringiensis plasmid. The 27,340 Da polypeptide synthesized in vito from pIP174 transformed into E. coli JM101 and from B. subtilis 168 and spoOJ87 containing the 1.2 kb TaqI fragment from pIP173 was lethal to mosquito larvae.
    Type: Grant
    Filed: February 3, 1986
    Date of Patent: April 17, 1990
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: David J. Ellar, Elizabeth S. Ward
  • Patent number: H875
    Abstract: Novel nucleic acid fragments coding for insecticidal proteins, the insecticidal proteins encoded thereby, insecticidal compositions containing such proteins, and the use of these proteins in combatting insects, particularly mosquitoes, are described. Chimeric genes containing the novel nucleic acid fragments, and microorganisms, tissues, seeds, and plants incorporating the nucleic acid fragments are also discussed.
    Type: Grant
    Filed: March 18, 1988
    Date of Patent: January 1, 1991
    Assignee: E. I. Du Pont de Nemours and Company, Inc.
    Inventors: David J. Ellar, Elizabeth S. Ward